BeautyHealth Q3 net sales $78.8M (-19% YoY); adj. EBITDA $8.1M, revenue guidance cut, EBITDA raised

SkinHealth Systems Inc.

2024-Q3 EPS reported -$0.31 revenue$250,799,000

Q3 net sales $78.8M, down 19.1% YoY; delivery systems sales fell 46% to $27.6M, consumables up 10% to $51.2M.
Net loss narrowed to $18.3M from $73.8M; GAAP gross margin improved to 51.6% from -12.9% YoY.
Adjusted EBITDA $8.1M vs $9.1M; adjusted EBITDA margin 10.2% vs 9.3%.
Full-year net sales guidance lowered; adjusted EBITDA guidance improved citing Q3 profitability.
Centralized manufacturing in Long Beach by year-end, ending China partner relationship; new CRO and CMO hired.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.